Skip to content

Boston Scientific BSX Price / earnings

Price / earnings at other companies

Abbott logo
AbbottABT
28.4×+11.4×
Johnson & Johnson logo
Johnson & JohnsonJNJ
28×+9.7×
Stryker logo
StrykerSYK
37.7×-12.0×
Edwards Lifesciences logo
Edwards LifesciencesEW
42.1×+32.0×
Medtronic logo
MedtronicMDT
21.7×-1.5×
STERIS logo
STERISSTE
27.7×-8.5×

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.4%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$66.81B-37.5%
P/S3.2×-2.8×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Calculated from Boston Scientific’s reported figures.

Based on the most recent quarter.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's price / earnings?
Boston Scientific (BSX) reported price / earnings of 26.2× in Q1 2026.
How has Boston Scientific's price / earnings changed year-over-year?
Boston Scientific's price / earnings decreased by 64.5% year-over-year, from 73.7× to 26.2×.
What is the long-term trend for Boston Scientific's price / earnings?
Over 3 years (2022 to 2025), Boston Scientific's price / earnings has grown at a -9.5% compound annual growth rate (CAGR), from 318.3× to 236.2×.
What does price / earnings mean?
How many dollars investors pay for each dollar of the company's annual profit.
How do you interpret price / earnings?
Lower can mean cheaper — or that the market expects earnings to fall. High multiples embed growth expectations. Meaningless when earnings are negative, so it is suppressed there.
How does price / earnings compare across companies?
Compare against the company's own history and sector peers, not across sectors with different growth and risk profiles.